Last update 24 Sep 2025
STUDY GROUP UK LTD

STUDY GROUP UK LTD

Holding Company|1994|United Kingdom|
1,000-5,000
|
dignityfunerals.co.uk

Overview

Tags

Other Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
GABAB receptor(Gamma-Aminobutyric Acid B Receptor)1

Related

1
Drugs associated with STUDY GROUP UK LTD
ASP-8062
Target
GABAB receptor
Mechanism
GABAB receptor modulators
Active Org.
Gilgamesh Pharmaceuticals, Inc.Gilgamesh Pharmaceuticals, Inc.
 [+1]
Originator Org.
Astellas Pharma, Inc.Astellas Pharma, Inc.
Active Indication
Opioid abuse
Inactive Indication
Alcohol Use Disorder [+2]
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with STUDY GROUP UK LTD
ChiCTR2400086568
/ RecruitingEarly Phase 1IIT
A multicentre, randomised controlled study of a self-proposed Wenyangtongluo Fang for the treatment of oxaliplatin-associated peripheral neurotoxicity
ChiCTR2200061340
/ Not yet recruitingNot ApplicableIIT
Effect of perioperative application of tozumab on the prognosis of CAS in patients with severe symptomatic carotid stenosis
100 Clinical Results associated with STUDY GROUP UK LTD
Login to view more data
0 Patents (Medical) associated with STUDY GROUP UK LTD
Login to view more data
100 Deals associated with STUDY GROUP UK LTD
Login to view more data
100 Translational Medicine associated with STUDY GROUP UK LTD
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 31 Oct 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
ASP-8062
 ( GABAB receptor )		Opioid abuse
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free